Multiple senolytic clinical trials are actively recruiting in the US and internationally as of 2026. Trial participation provides free access to physician-supervised senolytic treatment, comprehensive safety monitoring, and contribution to science — at no cost to participants. The primary barrier is meeting eligibility criteria, which typically include age (≥65), specific health characteristics, and geographic proximity to a trial site.

Can I continue taking supplement senolytics while in a clinical trial?

Always disclose all supplements to trial investigators. Some trials exclude participants taking senolytics or require a washout period. Others allow continuation of supplements. Never conceal supplement use from trial staff.

What if I'm randomized to placebo?

Placebo assignment is frustrating but provides essential scientific data. After trial completion, many trials offer open-label extension periods where all participants receive active treatment. Ask the trial team about post-trial access.